Blockchain in Genomics Market
Report ID: SQMIG35G2492
Report ID: SQMIG35G2492
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35G2492 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
176
|Figures:
79
Global Blockchain In Genomics Market size was valued at USD 1.06 Billion in 2024 and is poised to grow from USD 1.18 Billion in 2025 to USD 2.73 Billion by 2033, growing at a CAGR of 11.1% during the forecast period (2026-2033).
Global Blockchain in Genomics Market merges distributed ledger technology with DNA sequencing data to form a secure, auditable ecosystem for researchers, clinicians and patients. The main driver behind this is the need for data integrity and privacy as genomic information becomes essential for personalized medicine and drug development. Sequencers have generated petabytes of data in the last 10 years that need to be transferred between institutions under GDPR and HIPAA regulations. Pilot projects like Illumina’s partnership with IBM Watson Health highlighted the benefits of immutable records for simplifying the consent management process and reducing fraud, attracting venture funding and turning an experiment into a growing market.
Besides security, the market is also growing because blockchain allows for data marketplaces where genomic datasets can be tokenized and licensed as needed. Where researchers can access curated sequences that can be verifiably checked, drug discovery cycles are shorter, R&D costs are lower, and clinical trials are faster. For example, Nebula Genomics has launched a platform which pays participants in cryptocurrency to share their genome data. This is an example of how patient consent can be monetised. The model establishes a feedback loop: more data from contributors, attracting pharma partners looking for rare variants, driving investment and scaling the ecosystem.
How is blockchain adoption impacting data security and collaboration in the genomics market?
Global Blockchain in Genomics Market merges distributed ledger technology with DNA sequencing data to form a secure, auditable ecosystem for researchers, clinicians and patients. The main driver behind this is the need for data integrity and privacy as genomic information becomes essential for personalized medicine and drug development. Sequencers have generated petabytes of data in the last 10 years that need to be transferred between institutions under GDPR and HIPAA regulations. Pilot projects like Illumina’s partnership with IBM Watson Health highlighted the benefits of immutable records for simplifying the consent management process and reducing fraud, attracting venture funding and turning an experiment into a growing market.
Besides security, the market is also growing because blockchain allows for data marketplaces where genomic datasets can be tokenized and licensed as needed. Where researchers can access curated sequences that can be verifiably checked, drug discovery cycles are shorter, R&D costs are lower, and clinical trials are faster. For example, Nebula Genomics has launched a platform which pays participants in cryptocurrency to share their genome data. This is an example of how patient consent can be monetised. The model establishes a feedback loop: more data from contributors, attracting pharma partners looking for rare variants, driving investment and scaling the ecosystem.
Market snapshot - (2026-2033)
Global Market Size
USD 1.06 Billion
Largest Segment
Software
Fastest Growth
Services
Growth Rate
11.1% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global blockchain in genomics market is segmented by component, deployment type, application, blockchain type, end user, organization size and region. Based on component, the market is segmented into Hardware, Software and Services. Based on deployment type, the market is segmented into Cloud-Based, On-Premises and Hybrid. Based on application, the market is segmented into Genomic Data Storage & Management, Data Sharing & Collaboration, Clinical Trials & Research, Precision Medicine, Identity & Consent Management and Others. Based on blockchain type, the market is segmented into Public Blockchain, Private Blockchain, Consortium Blockchain and Hybrid Blockchain. Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Providers, Genomic Research Institutes, Contract Research Organizations (CROs) and Others. Based on organization size, the market is segmented into Large Enterprises and Small & Medium Enterprises (SMEs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
What role does software play in transforming the blockchain in genomics market?
The software segment is anticipated to be the largest segment owing to its ability to translate the genomic data into actionable insights through smart contracts and immutable ledgers, which can be easily integrated with the existing bioinformatics pipelines. It is flexible enough for developers to embed blockchain logic in analysis tools, enabling trust and reproducibility. Furthermore, the lower barrier to entry for software solutions is a major driver of the market activity in the emerging market activity and accelerates adoption in both research and clinical settings.
The Hardware segment, however, is witnessing the highest growth momentum owing to the increasing demand for specialized nodes and secure enclaves to protect sensitive genomic sequences. Tamper proof devices and edge computing innovations make real-time verification possible, drawing in biotech firms wanting to comply. This uptake is driving broader market development and new partnership opportunities.
The cloud based deployment is leader in the sense that it provides scalable infrastructure that matches the huge data volume generated by genomic sequencing, whilst providing on demand access to distributed ledger services. Researchers can quickly provision resources, collaborate with colleagues around the world, and leverage existing cloud analytics, accelerating time to insight. In today’s world, the elasticity and cost-effectiveness of cloud models make them the preferred choice to accelerate blockchain adoption in genomics, be it for research or clinical applications.
The growth area is hybrid deployment as companies seek to find a balance between data sovereignty and analytics, he said. Consortium models enabled by cloud elasticity for large-scale computation and regulatory expectations (met with on-premises control) for sensitive patient records. This is contributing to accelerated market take-up and stimulating innovation in service provision.
To get detailed segments analysis, Request a Free Sample Report
North America has an advanced research ecosystem, private investment and a mature regulatory environment that supports data interoperability. The United States has world-class academic institutions and biotech companies at the forefront of using decentralized technologies to share genomic data securely. Canada’s robust public health infrastructure and collaborative networks focused on patient-centred data stewardship. This combined, creates a solid base for the deployment of blockchain solutions, attracting global talent and developing partnerships that speed up product development. The emerging field is North America-centric in terms of innovation and commercial applications, and the region’s commitment to ethical standards and transparent consent mechanisms are helping to build trust among stakeholders.
The U.S. Blockchain in Genomics market is driven by a vibrant venture capital market and a culture of technology experimentation that spurs startups to explore decentralized data models. There is a lot of collaboration between big pharma and academic centers and they are doing pilot projects on secure data sharing. And there is a progressive legal framework that is supporting the development of consent driven blockchain platforms. The ecosystem will benefit from interdisciplinary talent pools that combine expertise in bioinformatics, cryptography and health policy, creating solutions that tackle both scalability and privacy concerns.
Canada’s Blockchain in Genomics Market is shaped by a public health agenda that promotes equitable access to genomic services and a government that is supportive of digital health innovation. Universities, hospitals and technology companies are partnering up in collaborative research consortia to investigate the use of blockchain for patient-controlled data repositories. Privacy laws are being used to design consent-based blockchain systems that meet national data protection laws, allowing for secure cross-border collaborations while protecting patient trust.
A strong commitment to data protection, a collaborative research culture and strategic investment in digital health infrastructure are driving Europe’s expansion. The EU’s extensive privacy rules create a trusted environment that fosters the use of blockchain for protecting genomic information. In major countries, national health systems are actively looking for decentralized platforms to facilitate secure cross-border data exchange, to enable multinational research projects. The combination of academic excellence and the increasing number of biotech startups accelerates the development of interoperable solutions. Furthermore, public-private partnerships make use of funding mechanisms to deploy blockchain pilots that tackle the ethics of consent and ownership of data, reinforcing Europe’s role as a leader in responsible innovation of genomic data.
The Blockchain in Genomics Market in Germany is driven by the strong biotech industry, and research history in precision medicine. Top research institutes are partnering with tech companies to develop blockchain architectures that can ensure the traceability and integrity of genomic datasets. In such a regulatory environment, patient consent and data sovereignty are very relevant, and this has driven the development of decentralized platforms that conform to national standards. Strong industrial clusters are the basis to commercialize these innovations and make Germany a big player on the European market.
The UK Blockchain in Genomics market is expanding at a rapid pace, owing to increased startup activity and progressive health policy initiatives. Government programs are pushing health services to adopt more blockchain to help improve patient empowerment and the security of their data. Scientists in genomics, fintech innovators and legal experts are joining forces at centers to co-create solutions that strike a balance between accessibility and strong privacy protections. It’s a collaborative environment that’s driving adoption and making the UK one of the leading growth engines in the European landscape.
In France, strategic partnerships between academic labs and start-up technology companies are fueling the rise of the Blockchain in Genomics Market. Ethical management of genetic data is emphasized and blockchain frameworks for consent management and data provenance are proposed. National health programs are funding pilot projects that encourage a culture of collaboration in rare disease research through decentralized data sharing. These programs, and a growing community of innovators, are signs of France’s growing influence in the broader European market.
Asia Pacific is gaining momentum with rapid digital transformation, large scale genomic research programs and strong government support for health technology innovation. Countries across the region are investing in high performance computing and data infrastructure that can complement blockchain’s ability to securely and scalably handle genomic data. Cross-sector networks, incorporating academia, biotech and fintech, accelerate the creation of region-specific blockchain solutions that take into account local regulatory nuances and cultural expectations around data privacy. The emphasis on open data ecosystems, and cross-border research consortia, makes the region more attractive for multinational collaborations, creating Asia Pacific as an emerging hub for next-generation genomic data stewardship.
The advanced research institutions and progressive regulation encouraging secure data sharing support Japan’s blockchain in genomics market. National health programs are advocating the use of blockchain for the secure storage of patient data and for collaborative research across the Asia Pacific. Biotech companies are partnering with technology companies to develop easy-to-use platforms that adhere to cultural norms around privacy and consent which is resulting in greater adoption by healthcare providers and patients.
A thriving biotechnology ecosystem and a countrywide push for digital health are driving the Blockchain in Genomics market in South Korea. The government is providing incentives for startups to create blockchain tools for safe storage and sharing of genomic data. The top hospitals are trying out decentralized platforms to enhance clinical decision making. South Korea’s growing stature in the regional landscape is further enhanced by blockchain solutions that focus on interoperability and patient-centric consent mechanisms that are in line with regulatory standards and market demands.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Adoption Of Blockchain Platforms
Leveraging Smart Contracts For Data Monetization
Regulatory Uncertainty Limits Adoption
High Implementation Costs Hinder Scale
Request Free Customization of this report to help us to meet your business objectives.
The competition is a race to get immutable privacy-preserving genomic data on blockchain, which drives partnerships and strategic capital injections. The recent $20 million investment by GEM Digital in Genomes.io shows blockchain specialists lining up with genomics companies to speed product roll-outs, while established players are buying up niche data-storage startups to expand their secure-sharing ecosystems.
Our Business Information Services team, ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) of SkyQuest Collects, Collates, Correlates and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the growing use of blockchain platforms for securing DNA data and enabling collaboration between institutions, use of smart contracts for monetizing genomic datasets and enabling consent are the key factors driving the growth of the global blockchain in genomics market. The software segment is predicted to dominate the market as it embeds the blockchain logic into bioinformatics tools which leads to quick adoption in research and clinical settings. North America remains the dominant region, due to its mature biotech ecosystem, ample venture funding and a supportive regulatory environment. However, until harmonized standards are developed, regulatory uncertainty across jurisdictions delays broader implementation.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 1.06 Billion |
| Market size value in 2033 | USD 2.73 Billion |
| Growth Rate | 11.1% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Blockchain in Genomics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Blockchain in Genomics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Blockchain in Genomics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Blockchain in Genomics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Blockchain In Genomics Market size was valued at USD 1.06 Billion in 2024 and is poised to grow from USD 1.18 Billion in 2025 to USD 2.73 Billion by 2033, growing at a CAGR of 11.1% during the forecast period (2026-2033).
The competitive landscape is shaped by a race to secure immutable, privacy‑preserving genomic data through blockchain, driving partnerships and strategic capital infusions. Genomes.io’s recent $20 million investment from GEM Digital exemplifies how blockchain specialists are aligning with genomics firms to accelerate product rollout, while incumbents pursue acquisitions of niche data‑storage startups to broaden their secure‑sharing ecosystems. 'Genetic Technologies Limited', 'Nebula Genomics, Inc.', 'Shivom Ventures Limited', 'EncrypGen, Inc.', 'Genomes.io Ltd.', 'BurstIQ, Inc.', 'Longenesis Ltd.', 'Embleema, Inc.', 'Guardtime AS', 'MedRec Technologies', 'Genobank.io', 'Zenome.io', 'Veritas Genetics, Inc.', 'DNAnexus, Inc.', 'Lifebit Biotech Ltd.', 'FarmaTrust Ltd.', 'Solve.Care Foundation', 'HOPPR Inc.', 'SimplyVital Health, Inc.', 'Patientory Inc.'
The increasing adoption of blockchain platforms in genomic research creates a secure and immutable environment for data exchange, fostering collaboration among institutions and encouraging the integration of diverse datasets. This trust‑enhanced infrastructure reduces concerns about data tampering and privacy breaches, prompting researchers and clinical laboratories to incorporate blockchain solutions into their workflows. As a result, the market experiences heightened demand for specialized blockchain services, tools, and consulting that support genomic data management and analytical pipelines. These efforts are increasingly recognized across pharmaceutical, research, and personalized medicine sectors globally.
Interoperability Standards Rising: The genomic data ecosystem is converging on shared blockchain protocols that enable seamless exchange of sequence information across research institutions, clinical labs, and pharmaceutical partners. By adopting open-ledger frameworks, stakeholders reduce data silos, accelerate collaborative studies, and ensure provenance tracking while preserving participant consent. This shift toward standardized smart‑contract templates fosters trust, streamlines cross‑border collaborations, and positions blockchain as the connective tissue underpinning next‑generation precision medicine initiatives worldwide. Regulators increasingly recognize these ledgers as compliance evidence.
Why does North America Dominate the Global Blockchain in Genomics Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
